NGVT
Get informed when a big investor buys or sells
+ FollowOvervalued by 78.5% based on the discounted cash flow analysis.
| Market cap | $2.51 Billion |
|---|---|
| Enterprise Value | $3.61 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.61 |
| Beta | 1.17 |
| Outstanding Shares | 35,300,000 |
| P/E Ratio | -20.59 |
|---|---|
| PEG | -10.74 |
| Price to Sales | 2.15 |
| Price to Book Ratio | 72.94 |
| Enterprise Value to Revenue | 2.98 |
| Enterprise Value to EBIT | -34.66 |
| Enterprise Value to Net Income | -29 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 30.96 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 18.71% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.40%▼ 100.23% |
|---|---|
| Total Invested | $10.66M▼ 99.58% |
| Investors Holding | 17▼ 290.00% |
No data
Ingevity provides specialty chemicals, high-performance carbon materials and engineered polymers that purify, protect and enhance the world around us. Through a team of talented and experienced people, Ingevity develops, manufactures, an...